Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Oct 15;11(10):1562. doi: 10.3390/cancers11101562

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Figure A3 — Kaplan-Meier survival curves of TMB/TGF- $β$ score positive cases (blue line) versus TMB/TGF- $β$ score negative cases (red line) in the context of the cancer types according to the recommendations reported in Liu et al. [22] (A) Overall Survival (adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), uterine corpus endometrial carcinoma (UCEC), skin cutaneous melanoma (SKCM), head and neck squamous cell carcinoma (HNSC), kidney renal papillary cell carcinoma (KIRP), pancreatic adenocarcinoma (PAAD), sarcoma (SARC), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), colon adenocarcinoma (COAD), lung squamous cell carcinoma (LUSC), liver hepatocellular carcinoma (LIHC), uterine carcinosarcoma (UCS), lung squamous cell carcinoma (LUSC), cholangiocarcinoma (CHOL), lung adenocarcinoma (LUAD), mesothelioma (MESO), uveal melanoma(UVM), ovarian serous cystadenocarcinoma (OV), esophageal carcinoma (ESCA), stomach adenocarcinoma (STAD), glioblastoma multiforme (GBM)); (B) Disease-specific survival (adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), uterine corpus endometrial carcinoma (UCEC), skin cutaneous melanoma (SKCM), head and neck squamous cell carcinoma (HNSC), kidney renal papillary cell carcinoma (KIRP), pancreatic adenocarcinoma (PAAD), sarcoma (SARC), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), colon adenocarcinoma (COAD), lung squamous cell carcinoma (LUSC), uterine carcinosarcoma (UCS), glioblastoma multiforme (GBM),lung adenocarcinoma (LUAD), mesothelioma (MESO), uveal melanoma (UVM), ovarian serous cystadenocarcinoma (OV), esophageal carcinoma (ESCA), stomach adenocarcinoma (STAD); (C) Progression-free interval (adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), uterine corpus endometrial carcinoma (UCEC), skin cutaneous melanoma (SKCM), head and neck squamous cell carcinoma (HNSC), prostate adenocarcinoma (PRAD), pancreatic adenocarcinoma (PAAD), kidney renal papillary cell carcinoma (KIRP), sarcoma (SARC), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), colon adenocarcinoma (COAD), lung squamous cell carcinoma (LUSC), liver hepatocellular carcinoma (LIHC), breast invasive carcinoma (BRCA), thyroid carcinoma (THCA), uterine carcinosarcoma (UCS), brain lower grade glioma (LGG), cholangiocarcinoma (CHOL), lung adenocarcinoma (LUAD), testicular germ cell tumors (TGCT), mesothelioma (MESO), ovarian serous cystadenocarcinoma (OV), esophageal carcinoma (ESCA), stomach adenocarcinoma (STAD)). Time is expressed in days; log-rank test p-value is reported.